How to Help Your Patients Find YF-Vax in Stock: A Provider's Guide

When a patient comes to your office asking about yellow fever vaccination before an upcoming trip, a positive first step is knowing whether you can help them right there — and what to do if you can't. YF-Vax, the only FDA-licensed yellow fever vaccine in the United States, comes with specific distribution and authorization requirements that make patient access more complex than most other vaccines.

This guide is designed to help healthcare providers — whether you're a travel medicine specialist, infectious disease physician, or primary care provider — counsel patients effectively and navigate the logistical challenges of YF-Vax access in 2026.

First: Is Your Practice an Authorized Vaccination Center?

Only clinics holding a valid Yellow Fever Vaccination Stamp from their state or territorial health department are authorized to order and administer YF-Vax. If your practice does not hold this designation, you cannot order or administer the vaccine, and you'll need to refer patients to a certified center.

If you're interested in becoming an authorized center, contact your state health department for information on the application and stamping process. Many primary care offices and pharmacies that serve international travelers can and do obtain this authorization.

Counseling Patients Before Referral: Key Points

Whether or not you administer YF-Vax yourself, every provider whose patients travel internationally should be prepared to counsel them on:

Timing: The ICVP does not become valid until 10 days post-vaccination. Patients should ideally receive the vaccine 4–6 weeks before departure to accommodate scheduling and any co-administered travel vaccines.

Country-specific requirements vs. recommendations: Many patients confuse 'recommended' and 'required.' For countries where vaccination is required for entry, the ICVP is mandatory, and some will also require it if the traveler is transiting through an endemic area. Direct patients to the CDC Travelers' Health site or to a travel medicine consultation.

Who should NOT receive the vaccine: Screen for absolute contraindications: age <6 months, severe immunodeficiency, thymus disorders, hypersensitivity to vaccine components. Note precautions for patients ≥60 years (significantly increased serious adverse event risk), pregnant or breastfeeding patients, and those with HIV.

Lifetime protection: A single dose of YF-Vax provides lifelong protection for most healthy individuals. Under current WHO and IHR guidelines, a booster is not required. Reassure patients who received the vaccine years ago that they are still protected — as long as they have a valid ICVP.

How to Refer Patients to an Authorized YF-Vax Provider

When referring a patient to a yellow fever vaccination center, the most important tools are:

CDC Yellow Fever Clinic Finder: The CDC Travelers' Health website hosts a searchable directory of authorized vaccination centers. This should be your primary referral tool.

Call ahead: Authorized centers don't always carry current stock. Encourage patients to call ahead to confirm that YF-Vax is in stock before making the trip.

medfinder: For patients who don't have time to call multiple clinics, medfinder contacts authorized clinics in the patient's area to check current stock, then texts the results. This is particularly helpful for time-constrained patients or those in areas with fewer authorized centers.

Managing Patients with Contraindications or Precautions

For patients with absolute contraindications, discuss the option of a Medical Letter of Exemption. Be clear that:

Not all countries accept medical waivers in lieu of proof of vaccination.

The patient must check with the destination country's embassy or consulate about waiver acceptance.

For patients ≥60 years, a careful risk-benefit discussion is essential. The incidence of YEL-AVD rises to 1.2 per 100,000 doses in this age group. Document this counseling clearly.

For HIV-positive patients with CD4 counts between 200–499 cells/mm³ and suppressed viral load, vaccination may be considered. Antibody response may be diminished; documentation of a protective antibody response before travel is recommended. Contact the CDC at 1-970-221-6400 for specific guidance in these cases.

Practical Tips for Authorized Vaccination Centers

Schedule multiple patients simultaneously when using the 5-dose multi-dose vial. Reconstituted vaccine must be used within 60 minutes.

Maintain proper cold chain: store at 2°–8°C; do not freeze YF-Vax or its diluent.

Always complete and stamp the ICVP immediately after vaccination. Record the date, lot number, and manufacturer.

Advise patients to keep their ICVP in a safe, accessible location — it is valid for life under current WHO guidelines and is required for future international travel.

medfinder for Providers: Streamline Medication Access for Your Patients

medfinder offers a dedicated portal for providers at medfinder.com/providers. Rather than leaving patients to call a dozen clinics on their own, you can direct them to medfinder to have us identify which authorized clinics near them currently have YF-Vax in stock. This is particularly useful when your own clinic doesn't carry the vaccine or when your patient is traveling to an unfamiliar city.

Related provider resources: YF-Vax shortage clinical overview for providers and helping patients save money on YF-Vax.